|
AKRO
|
Akero Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ALGS
|
Aligos Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BLTE
|
Belite Bio, Inc.
|
US
|
NASDAQ
|
|
ETNB
|
89bio, Inc.
|
US
|
NASDAQ
|
|
GALT
|
Galectin Therapeutics Inc.
|
US
|
NASDAQ
|
|
GLS
|
Gelesis Holdings, Inc.
|
US
|
NYSE
|
|
GLTO
|
Galecto, Inc.
|
US
|
NASDAQ
|
|
GNFT
|
GENFIT S.A.
|
US
|
NASDAQ
|
|
IVA
|
Inventiva S.A.
|
US
|
NASDAQ
|
|
MTCR
|
Metacrine, Inc.
|
US
|
NASDAQ
|
|
PLRX
|
Pliant Therapeutics, Inc.
|
US
|
NASDAQ
|
|
TERN
|
Terns Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
VKTX
|
Viking Therapeutics, Inc.
|
US
|
NASDAQ
|
|
337
|
Corbus Pharmaceuticals Holding
|
DE
|
F
|
|
3G0
|
Altimmune Inc
|
DE
|
F
|
|
PHPN
|
Galectin Therapeutics Inc
|
DE
|
F
|
|
293780
|
AptaBio Therapeutics Inc
|
KR
|
KQ
|
|
ALVAL
|
Valbiotis SAS
|
FR
|
PA
|
|
GNFT
|
Genfit
|
FR
|
PA
|
|
IVA
|
Inventiva S.A
|
FR
|
PA
|